Interventions to Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials

医学 肾脏疾病 内科学 随机对照试验 临床试验 血液透析 透析 重症监护医学
作者
Chelsea Xu,Edward R Smith,Mark Tiong,Irene Ruderman,Nigel D Toussaint
出处
期刊:Journal of the American Society of Nephrology [American Society of Nephrology]
卷期号:: ASN.2021101327-ASN.2021101327 被引量:1
标识
DOI:10.1681/asn.2021101327
摘要

Background Vascular calcification is associated with cardiovascular morbidity and mortality in people with chronic kidney disease (CKD). Evidence-based interventions that may attenuate its progression in CKD remain uncertain. Methods We conducted a systematic review of prospective clinical trials of interventions to attenuate vascular calcification in people with CKD, compare with placebo, another comparator, or standard of care. We included prospective clinical trials (randomized and nonrandomized) involving participants with stage 3-5D CKD or kidney transplant recipients; the outcome was vascular calcification measured using radiological methods. Quality of evidence was determined by the Cochrane risk of bias assessment tool and the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) method. Results There were 77 trials (63 randomized) involving 6898 participants eligible for inclusion (median sample size, 50; median duration, 12 months); 58 involved participants on dialysis, 15 involved individuals with nondialysis CKD, and 4 involved kidney transplant recipients. Risk of bias was moderate over all. Trials involving magnesium and sodium thiosulfate consistently showed attenuation of vascular calcification. Trials involving intestinal phosphate binders, alterations in dialysate calcium concentration, vitamin K therapy, calcimimetics, and antiresorptive agents had conflicting or inconclusive outcomes. Trials involving vitamin D therapy and HMG-CoA reductase inhibitors did not demonstrate attenuation of vascular calcification. Mixed results were reported for single studies of exercise, vitamin E-coated or high-flux hemodialysis membranes, interdialytic sodium bicarbonate, SNF472, spironolactone, sotatercept, nicotinamide, and oral activated charcoal. Conclusions Currently, there are insufficient or conflicting data regarding interventions evaluated in clinical trials for mitigation of vascular calcification in people with CKD. Therapy involving magnesium or sodium thiosulfate appears most promising, but evaluable studies were small and of short duration.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
4秒前
Likz完成签到,获得积分10
4秒前
不安的秋白完成签到,获得积分10
6秒前
清新的剑心完成签到 ,获得积分10
7秒前
Yiling完成签到,获得积分10
7秒前
9秒前
氕氘氚完成签到 ,获得积分10
13秒前
Hello应助不安的秋白采纳,获得10
15秒前
糯米团的完成签到 ,获得积分10
16秒前
神勇从波完成签到 ,获得积分10
18秒前
yellow完成签到 ,获得积分10
20秒前
虚幻元风完成签到 ,获得积分10
23秒前
xybjt完成签到 ,获得积分10
26秒前
巴达天使完成签到,获得积分10
32秒前
江三村完成签到 ,获得积分10
32秒前
量子星尘发布了新的文献求助10
50秒前
CyberHamster完成签到,获得积分10
1分钟前
xiaohong完成签到,获得积分10
1分钟前
朱比特完成签到,获得积分10
1分钟前
1分钟前
zmuzhang2019发布了新的文献求助10
1分钟前
onestepcloser完成签到 ,获得积分0
1分钟前
zoe完成签到 ,获得积分10
1分钟前
发嗲的慕蕊完成签到 ,获得积分10
1分钟前
Linson完成签到,获得积分10
1分钟前
顾矜应助赵三岁采纳,获得10
1分钟前
yyy2025完成签到,获得积分10
1分钟前
木雨亦潇潇完成签到,获得积分10
1分钟前
香蕉觅云应助nine2652采纳,获得10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
芳华如梦完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
土豆丝完成签到 ,获得积分10
1分钟前
琦琦完成签到,获得积分10
1分钟前
zzzz完成签到,获得积分20
2分钟前
GEZIKU完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038039
求助须知:如何正确求助?哪些是违规求助? 3575756
关于积分的说明 11373782
捐赠科研通 3305574
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022